February 18, 2021

Twist Bioscience and Victorian Clinical Genetic Services Collaborate on Development of Novel Whole Exome Capture Diagnostic Assay

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based specialist provider of prenatal, childhood and adult genetics services, today announced that together they have developed a novel whole exome capture assay. The assay, which utilizes Next Generation Sequencing (NGS) to co

Leave Comment

Your Name *
Your Email *
Your Website
Comment *